F. de Man

发表

Triglyceride‐rich lipoproteins in non‐insulin‐dependent diabetes mellitus: post‐prandial metabolism and relation to premature atherosclerosis

T. D. de Bruin, F. de Man, M. Castro Cabezas, 1996, European journal of clinical investigation.

Intravascular ultrasound versus angiography for measurement of luminal diameters in normal and diseased coronary arteries.

H De Geest, M. Herregods, W. Desmet, 1994, American heart journal.

Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study.

Maarten J. IJzerman, J. W. Louwerenburg, M. Stoel, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERS.

Maarten J. IJzerman, C. von Birgelen, G. Linssen, 2017, Journal of cardiology.

Scanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stents.

C. von Birgelen, F. de Man, M. Z. Basalus, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents

M. Stoel, C. von Birgelen, G. Linssen, 2018, Journal of the American Heart Association.

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.

M. Stoel, A. Roguin, C. von Birgelen, 2020, American heart journal.

Assessment of the relation between initial culprit vessel patency in acute ST-elevation myocardial infarction and endothelial function.

R. Peters, M. Stoel, C. von Birgelen, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Right atrial tumor arising on an atrial septal aneurysm. Assessment by MR imaging.

J. Bogaert, F. Rademakers, A. Baert, 1995, Clinical imaging.

Effects of mechanical compression of a fibrous tissue interface on bone with or without high-density polyethylene particles in a rabbit model of prosthetic loosening.

R. Marti, C. V. van Noorden, F. de Man, 2005, The Journal of bone and joint surgery. American volume.

Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy.

A. Van der Laarse, T. van Gent, H. Hattori, 2003, Journal of lipid research.

Drug-eluting stents not for all patients.

P. Doevendans, P. Stella, F. de Man, 2006, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Fractional flow reserve measurements to identify justified targets for PCI in patients with stable angina: FAME 2 and beyond.

C. von Birgelen, F. de Man, 2012, Cardiovascular diagnosis and therapy.

Five-Year Outcome After Implantation of Zotarolimus- and Everolimus-Eluting Stents in Randomized Trial Participants and Nonenrolled Eligible Patients: A Secondary Analysis of a Randomized Clinical Trial

M. Stoel, C. von Birgelen, G. Linssen, 2017, JAMA cardiology.

Comparison of frequency of periprocedural myocardial infarction in patients with and without diabetes mellitus to those with previously unknown but elevated glycated hemoglobin levels (from the TWENTE Trial).

J. W. Louwerenburg, M. Stoel, R. Stolk, 2012, The American journal of cardiology.

Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registry.

M. Stoel, C. von Birgelen, G. Linssen, 2014, International journal of cardiology.

Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy.

R. Nieuwland, A. Van der Laarse, F. Romijn, 2000, Atherosclerosis.

Hyperlipoproteinemia affects cytokine production in whole blood samples ex vivo. The influence of lipid-lowering therapy.

A. Weverling-Rijnsburger, R. Westendorp, F. de Man, 2000, Atherosclerosis.

The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.

F. H. Man, A. Van der Laarse, L. Havekes, 2000, Atherosclerosis.

Lipolysis of very low density lipoproteins by heparan sulfate proteoglycan-bound lipoprotein lipase.

A. Van der Laarse, L. Havekes, F. de Man, 1997, Journal of lipid research.

Normal Oxidative Stress and Enhanced Lipoprotein Resistance to In Vitro Oxidation in Hypertriglyceridemia: Effects of Bezafibrate Therapy

A. Van der Laarse, E. Schwedhelm, F. de Man, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.

F. H. Man, L. Havekes, F. de Man, 1998, Atherosclerosis.

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT.

J. W. Louwerenburg, M. Stoel, I. Knottnerus, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Insulin resistance but not hypertriglyceridemia per se is associated with endothelial dysfunction in chronic hypertriglyceridemia.

I. Jonkers, A. Van der Laarse, F. de Man, 2002, Cardiovascular research.

Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin.

J. Jukema, A. Weverling-Rijnsburger, J. Jukema, 2000, Arteriosclerosis, thrombosis, and vascular biology.

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.

J. W. Louwerenburg, M. Stoel, I. Knottnerus, 2018, International journal of cardiology.

Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia

A. Van der Laarse, A. Kamper, F. de Man, 2000, Journal of hypertension.

Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2018, JACC: Cardiovascular Interventions.

Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial.

M. Stoel, C. von Birgelen, G. Linssen, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.

C. von Birgelen, G. Linssen, F. de Man, 2015, American heart journal.

In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.

T. D. de Bruin, F. de Man, H. van Barlingen, 1996, Atherosclerosis.

Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Registry on a new T technique for bifurcation coronary lesions: the Utrech-"T"- experience.

P. Stella, B. Hamer, F. de Man, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry.

M. Stoel, C. von Birgelen, F. de Man, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial

M. Stoel, F. H. Man, C. von Birgelen, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study

M. Stoel, C. von Birgelen, G. Linssen, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Severe prosthetic joint infection in an immunocompetent male patient due to a therapy refractory Pseudallescheria apiosperma

J. Meis, J. Kluytmans, R. Wintermans, 2011, Mycoses.

Infectiological, functional, and radiographic outcome after revision for prosthetic hip infection according to a strict algorithm

W. Zimmerli, T. Ilchmann, F. de Man, 2011, Acta orthopaedica.

Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin.

M. Huisman, F. de Man, G. Blauw, 2001, Cardiovascular research.

Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy.

C. von Birgelen, F. de Man, G. V. van Houwelingen, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2018, JACC. Cardiovascular interventions.

Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a ‘procoagulant state': effects of bezafibrate therapy

I. Jonkers, R. Bertina, A. Van der Laarse, 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2012, Journal of the American College of Cardiology.

Reproducibility of volumetric intravascular ultrasound radiofrequency-based analysis of coronary plaque composition in vivo

M. Stoel, C. von Birgelen, F. de Man, 2008, The International Journal of Cardiovascular Imaging.

Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial.

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2013, Journal of the American College of Cardiology.

Small Stem Total Hip Arthroplasty in Hypoplasia of the Femur

R. Marti, F. de Man, D. Haverkamp, 2008, Clinical orthopaedics and related research.

Cemented hip revision surgery in severe acetabular defects using a semirigid acetabular reinforcement ring--a 5- to 25-year follow-up study.

R. Marti, F. de Man, D. Haverkamp, 2009, The Journal of arthroplasty.

Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomized Trial (TWENTE II).

Maarten J. IJzerman, M. Stoel, C. von Birgelen, 2015, JACC. Cardiovascular interventions.

Impact of analyzing fewer image frames per segment during offline volumetric radiofrequency-based intravascular ultrasound measurements of target lesions prior to percutaneous coronary interventions

Gary S. Mintz, Marc Hartmann, Clemens von Birgelen, 2011, The International Journal of Cardiovascular Imaging.

UvA-DARE ( Digital Academic Repository ) Clinical and experimental aspects of fixation , loosening , and revision of total hip replacement

F. de Man, D. Jong, F. H. R. de Man, 2009 .

Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial

J. Geleijnse, E. Adang, R. V. van Geuns, 2022, BMC Cardiovascular Disorders.

The long-term outcome of the cemented Weber acetabular component in total hip replacement using a second-generation cementing technique.

R. Marti, F. de Man, D. Haverkamp, 2009, The Journal of bone and joint surgery. British volume.

Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial.

C. von Birgelen, G. Linssen, C. Schotborgh, 2019, JAMA cardiology.

Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents: A Patient-Level Pooled Analysis From the TWENTE and DUTCH PEERS Trials.

Maarten J. IJzerman, J. W. Louwerenburg, A. Maas, 2016, JACC. Cardiovascular interventions.

Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and Xience V drug-eluting stents.

M. Stoel, C. von Birgelen, G. Linssen, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Incidence of periprocedural myocardial infarction following stent implantation: Comparison between first‐ and second‐generation drug‐eluting stents

M. Stoel, C. von Birgelen, G. Linssen, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Three‐year clinical outcome after treatment of chronic total occlusions with second‐generation drug‐eluting stents in the TWENTE trial

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Role of intravascular ultrasound in coronary artery disease: a new gold standard? An overview.

M. Herregods, F. de Man, H. De Geest, 1994, Acta cardiologica.

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

J. W. Louwerenburg, M. Stoel, C. von Birgelen, 2014, The Lancet.